R H Herzig
Overview
Explore the profile of R H Herzig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qiu L, Herzig R
Zhonghua Xue Ye Xue Za Zhi
. 2002 Mar;
21(8):417-20.
PMID: 11877015
Objective: To investigate the potential possibility that to expanse ex vivo umbilical cord blood (UCB) cells to an amount sufficient adults transplantation. Method: Purified CD(34)(+) UCB cells from 10 fresh...
2.
Lazarus H, Loberiza Jr F, Zhang M, Armitage J, Ballen K, Bashey A, et al.
Bone Marrow Transplant
. 2001 Apr;
27(4):387-96.
PMID: 11313668
Although patients with relapsed Hodgkin's disease have a poor prognosis with conventional therapies, high-dose chemotherapy and autologous hematopoietic stem cell transplantation (autotransplantation) may provide long-term progression-free survival. We reviewed data...
3.
Fleming D, Goldsmith J, Goldsmith G, Stevens D, Herzig R
J Hematother Stem Cell Res
. 2001 Feb;
9(6):855-60.
PMID: 11177597
Chemotherapy, in addition to recombinant growth factors, has been effective in mobilizing stem cells. Unfortunately, the use of chemotherapy for this purpose has resulted in profound myelosuppression and increased morbidity....
4.
Champlin R, Passweg J, Zhang M, Rowlings P, Pelz C, Atkinson K, et al.
Blood
. 2000 Jun;
95(12):3996-4003.
PMID: 10845940
T-cell depletion of donor marrow decreases graft-versus-host disease resulting from transplants from unrelated and human leukocyte antigen (HLA)-mismatched related donors. However, there are diverse strategies for T-cell-depleted transplantation, and it...
5.
Wolff S, Fay J, Stevens D, Herzig R, Pohlman B, Bolwell B, et al.
Bone Marrow Transplant
. 2000 May;
25(8):853-9.
PMID: 10808206
Systemic fungal infections are a major problem in bone marrow transplant recipients who have prolonged neutropenia or who receive high-dose corticosteroids. Prophylaxis with Fluconazole or low-dose amphotericin B reduces, but...
6.
Qiu L, Meagher R, Welhausen S, Heye M, Brown R, Herzig R
J Hematother Stem Cell Res
. 2000 Jan;
8(6):609-18.
PMID: 10645768
To investigate the clinically applicable conditions that support substantial expansion of both primitive and more mature hematopoietic cells of umbilical cord blood (UCB) for transplantation in adults, enriched CD34+ cells...
7.
Davies S, Ramsay N, Klein J, Weisdorf D, Bolwell B, Cahn J, et al.
J Clin Oncol
. 2000 Jan;
18(2):340-7.
PMID: 10637248
Purpose: Preparative regimens involving total-body irradiation (TBI) produce significant late toxicities in some children who receive bone marrow transplants, including impaired growth and intellectual development. Busulfan is often used as...
8.
Giralt S, Szydlo R, Goldman J, BIGGS J, Herzig R, Klein J, et al.
Blood
. 2000 Jan;
95(2):410-5.
PMID: 10627443
Allogeneic bone marrow transplantation (BMT) is the only curative therapy for chronic myelogenous leukemia (CML), though several studies indicate that prolonged survival can result from interferon-alpha (IFN-alpha) treatment. IFN-alpha is...
9.
Rowlings P, Williams S, Antman K, Fields K, Fay J, Reed E, et al.
JAMA
. 1999 Oct;
282(14):1335-43.
PMID: 10527180
Context: Women with breast cancer are the most frequent recipients of high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (autotransplants) in North America. Despite widespread use, controversy exists about...
10.
Fleming D, Wolff S, Fay J, BROWN R, Lynch J, Bolwell B, et al.
Leuk Lymphoma
. 1999 Oct;
35(1-2):91-8.
PMID: 10512166
To determine the long-term results of high-dose chemotherapy and stem cell support in relapsed or primary refractory Hodgkin disease patients. One hundred and thirty-one patients with relapsed or primary refractory...